Journal article · 2022 · Open access
Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis
Archiv der Pharmazie, 355(9), e2200095 · Published 31 May 2022 · DOI 10.1002/ardp.202200095
In brief
“Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis” is a 2022 journal article by Merlin Bresinsky and 12 co-authors, published in Archiv der Pharmazie. OpenAlex counts 9 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Archiv der Pharmazie.
- Citations
- 9
- Most cited in
- 2026 (3)
- Field-weighted impact
- 0.39
- References
- 46
- Authors
- 13
Abstract
Since the discovery of the caspase-2 (Casp2)-mediated ∆tau314 cleavage product and its associated impact on tauopathies such as Alzheimer's disease, the design of selective Casp2 inhibitors has become a focus in medicinal chemistry research. In the search for new lead structures with respect to Casp2 selectivity and drug-likeness, we have taken an approach by looking more closely at the specific sites of Casp2-mediated proteolysis. Using seven selected protein cleavage sequences, we synthesized a peptide series of 53 novel molecules and studied them using in vitro pharmacology, molecular modeling, and crystallography. Regarding Casp2 selectivity, AcITV(Dab)D-CHO (23) and AcITV(Dap)D-CHO (26) demonstrated the best selectivity (1-6-fold), although these trends were only moderate. However, some analogous tetrapeptides, most notably AcDKVD-CHO (45), showed significantly increased Casp3 selectivities (>100-fold). Tetra- and tripeptides display decreased or no Casp2 affinity, supporting the assumption that a motif of five amino acids is required for efficient Casp2 inhibition. Overall, the results provide a reasonable basis for the development of both selective Casp2 and Casp3 inhibitors.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bresinsky, M., Strasser, J. M., Hubmann, A., Vallaster, B., McCue, W. M., Fuller, J. L., Singh, G., Nelson, K. M., Cuellar, M. E., Finzel, B. C., Ashe, K. H., Walters, M. A., & Pockes, S. (2022). Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis. Archiv der Pharmazie, 355(9), e2200095. https://doi.org/10.1002/ardp.202200095
MLA 9
Bresinsky, Merlin, et al. “Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis.” Archiv der Pharmazie, vol. 355, no. 9, 2022, p. e2200095. https://doi.org/10.1002/ardp.202200095.
Chicago
Bresinsky, Merlin, Jessica M. Strasser, Alexander Hubmann, Bernadette Vallaster, William M. McCue, Jessica L. Fuller, Gurpreet Singh, et al. 2022. “Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis.” Archiv der Pharmazie 355 (9): e2200095. https://doi.org/10.1002/ardp.202200095.
Harvard
Bresinsky, M. et al. (2022) ‘Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis’, Archiv der Pharmazie, 355(9), p. e2200095. doi:10.1002/ardp.202200095.
IEEE
M. Bresinsky et al., “Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis,” Archiv der Pharmazie, vol. 355, no. 9, p. e2200095, 2022, doi: 10.1002/ardp.202200095.
BibTeX
@article{bresinsky2022characterization,
title = {{Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis}},
author = {Bresinsky, Merlin and Strasser, Jessica M. and Hubmann, Alexander and Vallaster, Bernadette and McCue, William M. and Fuller, Jessica L. and Singh, Gurpreet and Nelson, Kathryn M. and Cuellar, Matthew E. and Finzel, Barry C. and Ashe, Karen H. and Walters, Michael A. and Pockes, Steffen},
journal = {Archiv der Pharmazie},
year = {2022},
volume = {355},
number = {9},
pages = {e2200095},
doi = {10.1002/ardp.202200095},
url = {https://doi.org/10.1002/ardp.202200095}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 1 | |
| 2024 | 2 | |
| 2025 | 2 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.39: it has been cited 0.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- tau cleavage
- tauopathy
- Alzheimer's disease
- peptide inhibitors
- cleavage specificity
- drug-likeness
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Bresinsky, M., Strasser, J. M., Hubmann, A., Vallaster, B., McCue, W. M., Fuller, J. L., Singh, G., Nelson, K. M., Cuellar, M. E., Finzel, B. C., Ashe, K. H., Walters, M. A., & Pockes, S. (2022). Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis. Archiv der Pharmazie, 355(9), e2200095. https://doi.org/10.1002/ardp.202200095
How many times has this paper been cited?
9 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Archiv der Pharmazie: sign in and open the PDF from this page.
Who wrote this paper?
Merlin Bresinsky, Jessica M. Strasser, Alexander Hubmann, Bernadette Vallaster, William M. McCue, Jessica L. Fuller, Gurpreet Singh, Kathryn M. Nelson, Matthew E. Cuellar, Barry C. Finzel, Karen H. Ashe, Michael A. Walters and 1 more.
What is the DOI of this paper?
10.1002/ardp.202200095, permanently at https://doi.org/10.1002/ardp.202200095. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.